Abstract
Purpose of Review
The increasing prevalence of type 2 diabetes is driving the boundaries of clinical diabetes care outside of the traditional office setting. The purpose of this paper will be to review recent technological advances in the medical management of people with type 2 diabetes, spanning the spectrum of care from access to healthcare providers/educators, to continual virtual support methods, on-line management tools, and technologically integrated medication delivery systems.
Recent Findings
Recent findings support a potential positive impact of technology on access to care, clinical outcomes, convenience, patient well-being, and patient acceptance. This includes the use of Bluetooth-enabled glucose meters, continuous glucose monitors, mHealth apps, smartpens, and insulin pumps. However, there are impediments to the implementation of some technologies due to cost and lack of insurance coverage.
Summary
There is evidence to support the use of technology to improve the management and treatment of people with type 2 diabetes. Further research is required to demonstrate the long-term clinical benefit and financial viability of technology in the management of type 2 diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
National diabetes statistics report, 2017. Atlanta, GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2017.
Pew Research Center: https://www.pewresearch.org/fact-tank/2018/09/28/internet-social-media-use-and-device-ownership-in-u-s-have-plateaued-after-years-of-growth/).
Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Twelve-month outcomes of an internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr;87(1):81–92.
Maxwell LG, McFarland MS, Baker JW, Cassidy RF. Evaluation of the impact of a pharmacist-led telehealth clinic on diabetes-related goals of therapy in a veteran population. Pharmacotherapy. 2016;36:348–56. https://doi.org/10.1002/phar.1719.
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73.
•• Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. [Epub ahead of print 22 August 2017] 167:365–374. doi: https://doi.org/10.7326/M16-2855. Many studies have demonstrated improved glycemic control in subjects with type 1 diabetes using continuous glucose monitoring. Few studies have evaluated the impact and acceptability of CGM in people living with type 2 diabetes. This study demonstrates that CGM can improve glycemic control in adults with type 2 diabetes and that use of CGM was associated with a high degree of patient satisfaction.
Kooiman TJM, de Groot M, Hoogenberg K, Krijnen WP, van der Schans CP, Kooy A. Self-tracking of physical activity in people with type 2 diabetes a randomized controlled trial. Comput Inform Nurs. 2018 Jul;36(7):340–9. https://doi.org/10.1097/CIN.0000000000000443.
Raval AD, Nguyen MH, Zhou S, Grabner M, Barron J, Quimbo R. Effect of V-Go versus multiple daily injections on glycemic control, insulin use, and diabetes medication costs among individuals with type 2 diabetes mellitus. J Manag Care Spec Pharm. 2019;5:1–14. https://doi.org/10.18553/jmcp.2019.18438.
Aronson R, Reznik Y, Conget I, Castañeda JA, Runzis S, Lee SW, et al. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes Metab. 2016;18(5):500–7. https://doi.org/10.1111/dom.12642.
• Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv Nutr. 2017;8(3):449–462. Published 2017 May 15. doi:https://doi.org/10.3945/an.116.014100. This study reviews the effects of mHealth interventions for management and treatment of obesity and type 2 diabetes. While preliminary evidence is promising, more studies with larger sample sizes and long-term outcomes are needed.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Abigail Kennedy Grant and Lauren Golden declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Pharmacologic Treatment of Type 2 Diabetes
Rights and permissions
About this article
Cite this article
Grant, A.K., Golden, L. Technological Advancements in the Management of Type 2 Diabetes. Curr Diab Rep 19, 163 (2019). https://doi.org/10.1007/s11892-019-1278-3
Published:
DOI: https://doi.org/10.1007/s11892-019-1278-3